 |
AxoSim Technologies
Last updated: July 29, 2024
Founders: Lowry Curley, Michael Moore
USA | Funding: $10.5M (+)
Website: https://axosim.com/
AxoSim's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
Website: https://axosim.com/
AxoSim's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
